Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

183

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N07BC01	BUVIDAL	B	Buprenorphine - 96mg	96mg	Injectable solution prolonged release	34,835,645 L.L
A04AA02	KYTRIL	B	Granisetron (HCl) - 1mg	1mg	Tablet, film coated	2,765,628 L.L
C01DX12	CORVASAL 2MG	B	Molsidomine - 2mg	2mg	Tablet, scored	1,092,992 L.L
G03FB01	PROGYLUTON	B	Norgestrel - 0.5mg (tablet 2), Estradiol valerate - 2mg (tablet 1, tablet 2)		Tablet	193,513 L.L
J01AA04	TETRALYSAL	B	Lymecycline - 300mg	300mg	Capsule	796,899 L.L
L01CE01	HYCAMTIN IV	B	Topotecan HCl - 4mg	4mg	Injectable lyophilised powder for solution	52,580,031 L.L
N07BC01	BUVIDAL	B	Buprenorphine - 128mg	128mg	Injectable solution prolonged release	34,835,645 L.L
C09AA03	ZESTRIL	B	Lisinopril (dihydrate) - 10mg	10mg	Tablet	592,635 L.L
D06AX01	FUCIDIN	B	Fusidic acid (sodium salt) - 20mg/g	2%	Ointment	259,362 L.L
L01CE01	HYCAMTIN IV	B	Topotecan HCl - 4mg	4mg	Injectable lyophilised powder for solution	52,580,031 L.L
M05BA04	FOSAMAX 70MG ONCE WEEKLY	B	Alendronate - 70mg	70mg	Tablet	1,988,887 L.L
R05CB01	FLUIMUCIL	B	N-acetylcysteine - 600mg	600mg	Tablet, effervescent	567,102 L.L
A04AA02	KYTRIL	B	Granisetron (HCl) - 3mg/3ml	3mg/3ml	Injectable solution	3,711,693 L.L
A10BD09	INCRESYNC	B	Pioglitazone - 15mg, Alogliptin - 25mg		Tablet, film coated	3,897,143 L.L
B01AC27	UPTRAVI	B	Selexipag - 200mcg	200mcg	Tablet, film coated	275,097,581 L.L
C09AA03	ZESTRIL	B	Lisinopril (dihydrate) - 20mg	20mg	Tablet	636,981 L.L
C10AA01	ZOCOR	B	Simvastatin - 20mg	20mg	Tablet	976,526 L.L
D06AX01	FUCIDIN OINTMENT	B	Fusidic acid (sodium salt) - 2%	2%	Ointment	491,846 L.L
J01DH03	INVANZ	B	Ertapenem - 1g	1g	Injectable concentrated powder for solution	3,785,604 L.L
S01LA09	VABYSMO	B	Faricimab - 6mg/0.05ml	6mg/0.05ml	Injectable solution	54,991,170 L.L
A10BD09	INCRESYNC	B	Pioglitazone - 30mg, Alogliptin - 25mg		Tablet, film coated	3,897,143 L.L
B01AC27	UPTRAVI	B	Selexipag - 200mcg	200mcg	Tablet, film coated	613,462,617 L.L
C01DX12	CORVASAL 4MG	B	Molsidomine - 4mg	4mg	Tablet	492,742 L.L
D06AX01	FUCIDIN OINTMENT	B	Fusidic acid (sodium salt) - 2%	2%	Ointment	345,368 L.L
R05CB01	EXOMUC	B	N-acetylcysteine - 200mg	200mg	Granules for solution	529,474 L.L
S01XA18	RESTASIS	B	Ciclosporin - 0.5mg/ml	0.05%	Emulsion	4,100,063 L.L
A10BD11	JENTADUETO	B	Metformin - 1000mg, Linagliptin - 2.5mg		Tablet, film coated	3,542,369 L.L
B01AC27	UPTRAVI	B	Selexipag - 400mcg	400mcg	Tablet, film coated	275,097,581 L.L
C09AA04	COVERSYL ARGININE	B	Perindopril arginine - 10mg	10mg	Tablet, film coated	452,875 L.L
J05AF07	VIREAD	B	Tenofovir disoproxil - 245mg	245mg	Tablet, film coated	15,716,313 L.L

...

183

...